/ mRNA
/ Market Analysis
Why is Moderna’s Stock Gaining in Premarket Trading Today?
Moderna stock jumped in premarket trading after the FDA granted limited approval for mNEXSPIKE, a new COVID-19 vaccine.
June 02, 2025
Trump Admin. Reconsiders $590M Funding for Moderna’s Bird Flu Vaccine
The Trump administration is reconsidering a $590 million contract with Moderna for bird flu vaccine development.
February 27, 2025
Moderna Cuts 2025 Sales Forecast Amid Low Vaccine Demand, Stock Plummets
Moderna has lowered its 2025 sales forecast due to decreased demand for its Covid and RSV vaccines.
January 13, 2025
Moderna Slashes R&D Budget, Stock Plummets Amid Profitability Concerns
Moderna announced plans to slash its R&D budget by $1.1 billion by 2027.
September 12, 2024
Stocks to Watch Today: MRNA, META, and AMAT
Meta Platforms surged on strong earnings and AI progress, while Moderna plummeted after slashing its sales outlook and Applied Materials saw its stock drop after being denied funding under the CHIPS ...
August 01, 2024More from The Tokenist / mRNA
Stocks to Watch Today: TSLA, RIVN, and Moderna
June 26, 2024
Back to 
